The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.
OBJECTIVE
Radiosensitization has previously been demonstrated in a human colon cancer cell line (HT-29) following a 2 h exposure to low, clinically relevant concentrations (0.05-0.5 microM) of fluorodeoxyuridine (FdUrd) (15). The sensitizer enhancement ratio value (measured at 10% survival) plateaued at approximately 1.7 between 16 and 32 h following removal of drug. Parallel studies investigating the effect of FdUrd on the distribution of cells throughout the cell cycle found that the percentage of cells in early S-phase increased to approximately 70% during the same period that maximal radiosensitization was noted. As a follow-up to these findings, experiments have been designed to investigate the contribution of this early S-phase delay to radiosensitization.


METHODS
Synchronized populations of HT-29 cells have been obtained with three separate techniques. Two involve the induction of a reversible metaphase arrest (with high pressure N2O or colcemid) followed by a shakeoff of mitotic cells. The third uses a plant amino acid, mimosine, to induce a reversible block at the G1/S boundary. Flow cytometry was used to analyze the degree of synchrony based on bromodeoxyuridine (BrdUrd) uptake and propidium iodide (PI) staining. Radiation survival curves were obtained on these synchronized populations to investigate changes in radiosensitivity through the cell cycle. Additionally, levels of thymidylate synthase (TS), the primary target of FdUrd cytotoxicity, were measured in each phase of the cell cycle using the TS 106 monoclonal antibody against human TS.


RESULTS
Synchronization with mitotic shakeoff produced relatively pure populations of cells in G1; however, the degree of synchrony in early S-phase was limited both by cells remaining in G1 and by cells progressing into late S-phase. These techniques failed to reveal increased radiosensitivity in early S-phase at 10% survival. An 18 h exposure to mimosine resulted in populations that more closely resembled the early S-phase enrichment following FdUrd exposure and revealed increased radiosensitivity during early S-phase. TS levels were noted to be only 1.3 times higher in S phase than in G0/G1.


CONCLUSIONS
Radiation survival data from cells synchronized with mitotic shakeoff techniques suggest that early S-phase delay is unlikely to be the primary mechanism of FdUrd radiosensitization. In contrast, the increased sensitivity seen in early S-phase with mimosine synchronized cells is similar to that seen with FdUrd. Although confounding biochemical pertubations cannot be ruled out, these data continue to suggest an association between early S-phase enrichment and radiosensitization. The significance of TS inhibition as a mechanism of FdUrd radiosensitization remains unclear.
McGinn
C J
CJ
Department of Human Oncology, University of Wisconsin Medical School, Madison 53792.
Miller
E M
EM
Lindstrom
M J
MJ
Kunugi
K A
KA
Johnston
P G
PG
Kinsella
T J
TJ
D002453:Cell Cycle / Q000187:drug effects* / Q000502:physiology*; D002470:Cell Survival / Q000528:radiation effects; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy*; D003703:Demecolcine / Q000494:pharmacology; D005467:Floxuridine / Q000494:pharmacology*; D006801:Humans; D008898:Mimosine / Q000494:pharmacology; D009609:Nitrous Oxide / Q000494:pharmacology; D009711:Nucleotides / Q000096:biosynthesis; D011836:Radiation Tolerance / Q000187:drug effects* / Q000502:physiology*; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D016196:S Phase / Q000187:drug effects / Q000502:physiology; D013940:Thymidylate Synthase / Q000032:analysis / Q000037:antagonists & inhibitors; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000528:radiation effects
D009711:Nucleotides; D011838:Radiation-Sensitizing Agents; D005467:Floxuridine; D008898:Mimosine; D013940:Thymidylate Synthase; D009609:Nitrous Oxide; D003703:Demecolcine